Shalby Limited — Investor Meet, 27-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Shalby's Q4 FY26 consolidated revenue rose 9.4% to ₹295.5 Cr, with EBITDA surging 43.1% to ₹37.4 Cr and PAT increasing 251.4% to ₹18.5 Cr. For FY26, revenue grew 4.8% to ₹1168.2 Cr and PAT jumped 1706.6% to ₹34.7 Cr. Hospital occupancy improved to 48%, and ARPOB was ₹42,689. The MedTech (implants) business showed strong momentum, with Q4 revenue up 45% to ₹40.0 Cr and EBITDA up 140% to ₹3.7 Cr. The company plans to boost occupancy, diversify specialties, expand its footprint, and focus on prudent capital allocation and technology leverage. Management appears confident in growth drivers and operational efficiency.